#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Risk of Liver Damage Caused by Modern Systemic Antimycotics


Authors: M. Skořepová
Authors‘ workplace: Kožní klinika 1. LF UK a VFN, Praha přednosta doc. MUDr. J. Štork, CSc.
Published in: Čes-slov Derm, , 2004, No. 2, p. 59-61
Category:

Overview

Long-term systemic antimycotic therapy, which is necessary in dermatology indications as e.g.in onychomycosis, is associated with concern of certain risk of hepatotoxicity. The frequency of liverdamage after application of ketoconazole is 1:15 000, after terbinafine 1:45 000-50 000, after itraconazolepulse-therapy 3.2:100 000 and after intermittent fluconazole therapy 1.4:100 000. The safety ofmodern antimycotics is comparable e.g. with paracetamol (toxic reactions rate 5.5:100 000) oribuprofen (toxic liver damage appeared in 2 of 54 830 treated).

Key words:
systemic antimycotics - hepatotoxicity

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Dermatology & STDs Paediatric dermatology & STDs
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#